Spark Venture Management is a London-based venture capital firm founded in 2005, specializing in early-stage investments primarily in the technology, media, and healthcare sectors across the UK and Europe. With over 12 years of experience, the firm focuses on high-growth potential companies, providing equity investments to support their development from startup to eventual trade sale or initial public offering. Spark Venture Management is committed to leveraging its expertise to foster innovation and drive success in the consumer technology landscape.
MyOffer is an online platform that facilitates overseas study applications, primarily focusing on universities in the United Kingdom and Australia. Founded in 2014 and based in London, the company offers a search engine that provides access to over one million courses globally. Its myOffer feature utilizes Big Data and comprehensive analysis to recommend courses and universities tailored to users' academic backgrounds and preferences. In addition to course recommendations, MyOffer aims to guide students on various aspects of studying abroad, including overseas living and studying experiences. The company also plans to expand its services to include visa applications, accommodation, career planning, and employment support for international students. MyOffer operates as a subsidiary of UVIC Limited.
Simba Sleep is a London-based company that designs and manufactures a range of sleep products, primarily focusing on mattresses. Founded in 2015, the company offers innovative mattresses that combine thousands of lightweight comfort springs with precision-engineered foam to enhance sleep quality. Simba Sleep's product line includes mattresses, pillows, duvets, bedding, and bed bases, utilizing a unique four-layer cooling foam system supported by patented conical pocket springs. The company emphasizes the importance of sleep and aims to help customers achieve better rest. Products are available through select retail partnerships, such as John Lewis, as well as via online sales, with financing options provided for customers.
Simba Sleep is a London-based company that designs and manufactures a range of sleep products, primarily focusing on mattresses. Founded in 2015, the company offers innovative mattresses that combine thousands of lightweight comfort springs with precision-engineered foam to enhance sleep quality. Simba Sleep's product line includes mattresses, pillows, duvets, bedding, and bed bases, utilizing a unique four-layer cooling foam system supported by patented conical pocket springs. The company emphasizes the importance of sleep and aims to help customers achieve better rest. Products are available through select retail partnerships, such as John Lewis, as well as via online sales, with financing options provided for customers.
Sky Medical Technology Limited develops innovative neuromuscular electro-stimulation medical devices aimed at enhancing vascular health. Their flagship products include the geko device, which stimulates the common peroneal nerve to activate muscle pumps and improve blood flow, and the firefly device, designed for athletes to enhance lower limb circulation for quicker recovery. The company's OnPulse™ therapy represents a significant advancement in bioelectronic medicine, offering clinically proven solutions for various acute and chronic circulatory conditions, including the prevention of blood clots, treatment of swelling post-surgery, and management of non-healing wounds. These devices are utilized by healthcare professionals, including surgeons, nurses, physiotherapists, and podiatrists, across NHS and private hospitals, as well as in clinical studies. Sky Medical Technology distributes its products globally, reaching markets in Asia, Europe, the Middle East, and North America. Founded in 2006 and based in High Wycombe, United Kingdom, the company addresses the needs of over forty million individuals facing vascular-related health challenges.
Vigil is a privately owned New Zealand company founded in 2012. Our system improves healthcare outcomes in home based personal healthcare management, hospital and managed care environments. Our industry specific hardware and software packages can be tailored to meet individual customer needs and integrated into existing operational systems, improving cost efficiency, quality of care and healthcare outcomes. They are designed operate with different devices and applications, providing end-to-end connectivity that means device users [wearers], their friends and family and other service providers [carers] can easily access data about the wearer, their wellbeing, their location and their environment.
Haemostatix Ltd. is a biotechnology company based in Nottingham, United Kingdom, founded in 2003 as a spin-out from the University of Leicester. The company specializes in a peptide-based platform technology designed to develop innovative products for managing surgical bleeding, with potential applications in tissue repair and regenerative medicine. Its flagship product, PeproStat, is a topical coagulant that can be applied directly to wounds during surgery to effectively control bleeding. The technology is based on a specific peptide sequence that binds to fibrinogen, a crucial protein in clot formation, and can be adapted to various solid supports or soluble carriers. This platform underpins a promising pipeline of first-in-class products aimed at treating different forms of bleeding, including those associated with surgery, trauma, and leukaemia. As of 2016, Haemostatix operates as a subsidiary of Ergomed plc.
Zilico Limited is a Manchester-based company focused on developing diagnostic devices aimed at improving cancer detection, particularly cervical cancer. Utilizing electrical impedance spectroscopy technology, Zilico's flagship product, ZedScan, operates alongside colposcopy to provide real-time, objective assessments of cervical epithelial tissue. This technology addresses the limitations of traditional diagnostic methods, which often involve subjective interpretations. Zilico is actively working on two applications: one targeting the referral market and another aimed at the screening market, both designed to enhance diagnostic accuracy and reduce the subjectivity associated with current practices. Since its founding in 2006, Zilico has aimed to deliver significant health economic benefits and improve cancer screening programs. The company was previously known as Aperio Diagnostics Limited before rebranding in 2008.
Oxford Immunotec is a medical diagnostics company developing novel new tests for various diseases based on its innovative, patented T cell measurement technology. The company's first product is a TB test that diagnoses latent TB infection ( LTBI ) and TB disease. T-SPOT®.TB is an interferon gamma release assay ( IGRA ) which are designed to replace the century old Mantoux skin test ( TST ).
Alchemy Pharmatech Ltd is a UK-based company specializing in the development of innovative drug delivery platforms. Established in 2012 and located in Runcorn, the company focuses on creating intranasal delivery devices that facilitate the unit-dose and needle-free administration of dry powders. Their product range encompasses applications for generic medicines, vaccines, pediatric care, intensive care, and animal health. Alchemy Pharmatech's devices are designed to provide a smooth and efficient delivery experience while minimizing inter-operator variability, making them suitable for various therapeutic areas, including DNA vaccines, hormone replacement therapies, and pain management. The company collaborates with the pharmaceutical industry to enhance treatment options for healthcare professionals and their patients.
Celoxica Limited, based in Abingdon, United Kingdom, provides hardware-accelerated market data access and order execution solutions aimed at the financial services industry. Founded in 1996, the company specializes in ultra-low latency trading services, catering to the advanced trading community, including trading firms and banks engaged in high-frequency trading, market making, liquidity provision, algorithmic trading, and smart order routing. Celoxica offers a range of market data feed handlers covering major U.S. and European equities, options, futures, and foreign exchange markets. The company facilitates seamless connectivity for brokers and clients by managing inbound FIX, credit checks, and outbound native protocols to execution venues. With additional offices in Chicago and New York, Celoxica remains focused on meeting the growing demands for speed and efficiency in electronic trading.
Haemostatix Ltd. is a biotechnology company based in Nottingham, United Kingdom, founded in 2003 as a spin-out from the University of Leicester. The company specializes in a peptide-based platform technology designed to develop innovative products for managing surgical bleeding, with potential applications in tissue repair and regenerative medicine. Its flagship product, PeproStat, is a topical coagulant that can be applied directly to wounds during surgery to effectively control bleeding. The technology is based on a specific peptide sequence that binds to fibrinogen, a crucial protein in clot formation, and can be adapted to various solid supports or soluble carriers. This platform underpins a promising pipeline of first-in-class products aimed at treating different forms of bleeding, including those associated with surgery, trauma, and leukaemia. As of 2016, Haemostatix operates as a subsidiary of Ergomed plc.
Vivacta Limited is a medical diagnostics company based in Sittingbourne, UK, specializing in point-of-care testing solutions. The company has created an innovative piezofilm technology platform that enhances the development of near-patient diagnostic products, achieving sensitivity and dynamic range comparable to laboratory tests. Vivacta has successfully developed a diagnostic test for thyroid stimulating hormone (TSH) and is currently focused on creating a multiple analyte cardiovascular diagnostic test. This test aims to facilitate rapid diagnosis in emergency and acute care settings, addressing the urgent need for timely detection of potential heart attacks and related medical conditions.
Haemostatix Ltd. is a biotechnology company based in Nottingham, United Kingdom, founded in 2003 as a spin-out from the University of Leicester. The company specializes in a peptide-based platform technology designed to develop innovative products for managing surgical bleeding, with potential applications in tissue repair and regenerative medicine. Its flagship product, PeproStat, is a topical coagulant that can be applied directly to wounds during surgery to effectively control bleeding. The technology is based on a specific peptide sequence that binds to fibrinogen, a crucial protein in clot formation, and can be adapted to various solid supports or soluble carriers. This platform underpins a promising pipeline of first-in-class products aimed at treating different forms of bleeding, including those associated with surgery, trauma, and leukaemia. As of 2016, Haemostatix operates as a subsidiary of Ergomed plc.
Celoxica Limited, based in Abingdon, United Kingdom, provides hardware-accelerated market data access and order execution solutions aimed at the financial services industry. Founded in 1996, the company specializes in ultra-low latency trading services, catering to the advanced trading community, including trading firms and banks engaged in high-frequency trading, market making, liquidity provision, algorithmic trading, and smart order routing. Celoxica offers a range of market data feed handlers covering major U.S. and European equities, options, futures, and foreign exchange markets. The company facilitates seamless connectivity for brokers and clients by managing inbound FIX, credit checks, and outbound native protocols to execution venues. With additional offices in Chicago and New York, Celoxica remains focused on meeting the growing demands for speed and efficiency in electronic trading.
Oxford Immunotec is a medical diagnostics company developing novel new tests for various diseases based on its innovative, patented T cell measurement technology. The company's first product is a TB test that diagnoses latent TB infection ( LTBI ) and TB disease. T-SPOT®.TB is an interferon gamma release assay ( IGRA ) which are designed to replace the century old Mantoux skin test ( TST ).
Academia.edu is a platform for academics to share research papers. It aims to accelerate the world's research. Academics use Academia.edu to share their research, monitor deep analytics around the impact of their research, and track the research of academics they follow. Over 132 million academics have signed up to Academia.edu, adding 25 million papers. Academia.edu attracts over 52 million unique visitors a month. The company was founded in 2007 and is headquartered in San Francisco, California.
Celona Technologies Ltd. specializes in application data migration software designed to facilitate organizational changes. The company offers a suite of tailored software solutions that enable the seamless migration of applications, data, users, and processes without downtime. Key products include Celona Evolve, which manages the migration and bi-directional synchronization of application data and business processes, alongside features such as a management dashboard, migration scheduler, and exception management solutions. The company also provides Application Adaptors that support data migration from legacy systems to new applications. Celona Technologies serves diverse industries, including telecommunications, financial services, utilities, retail, and the public sector, addressing needs in billing, CRM, ERP, and inventory management. Founded in 2005 and headquartered in London, the company has expanded its presence to Europe and the Asia Pacific region.
Vivacta Limited is a medical diagnostics company based in Sittingbourne, UK, specializing in point-of-care testing solutions. The company has created an innovative piezofilm technology platform that enhances the development of near-patient diagnostic products, achieving sensitivity and dynamic range comparable to laboratory tests. Vivacta has successfully developed a diagnostic test for thyroid stimulating hormone (TSH) and is currently focused on creating a multiple analyte cardiovascular diagnostic test. This test aims to facilitate rapid diagnosis in emergency and acute care settings, addressing the urgent need for timely detection of potential heart attacks and related medical conditions.
OMGPOP is a leading developer of social games for facebook, iphone and the open web. With games on multiple social networks as well as its own destination site, the company is recognized as a leader in creating real-time game experiences.
Mind Candy Ltd. is a multi-brand entertainment company based in London, United Kingdom, that specializes in developing online games for children and families, primarily for mobile and tablet platforms. Founded in 2003, the company is best known for its flagship product, Moshi Monsters, an engaging online game designed for kids. In addition to this, Mind Candy offers Moshi Monsters Village, a gaming application, and Moshi Monsters Magazine, which features puzzles, stories, and creative activities. The company has expanded its offerings to include Moshi Monsters Music, a music application, and the Moshling app, which introduces users to whimsical characters. Recently, Mind Candy has also launched a sleep and mindfulness app for kids, featuring melodic stories and guided meditation sessions aimed at promoting relaxation and mindfulness among young users.
Antenova, Ltd. specializes in the design and supply of standard and custom antennas and radio frequency antenna modules. Founded in 1999 and headquartered in Stow-cum-Quy, United Kingdom, the company serves a diverse range of applications, including mobile handsets, adapters, portable devices, laptop computers, and various wireless devices. Antenova is recognized as a leading provider of high-performance antennas specifically for wireless machine-to-machine (M2M) and consumer electronic devices. The company has design, sales, and support centers in Taipei, Taiwan; Chicago, Illinois; and Shanghai, China, alongside manufacturing operations located in Taiwan and China.
Secerno is a technology leader in active database control, headquartered in Oxford, UK, with a US office in Bedminster, New Jersey. The company specializes in database security and compliance software, offering innovative solutions to protect against both known and unknown threats. Its flagship product, Secerno DataWall™, provides comprehensive database activity monitoring, policy enforcement, and compliance auditing. These solutions are designed to safeguard data access in various sectors, including financial services, healthcare, pharmaceuticals, retail, and government agencies. Secerno's offerings are available as both hardware and virtual appliances, ensuring flexibility in deployment to meet diverse customer needs.
Celoxica Limited, based in Abingdon, United Kingdom, provides hardware-accelerated market data access and order execution solutions aimed at the financial services industry. Founded in 1996, the company specializes in ultra-low latency trading services, catering to the advanced trading community, including trading firms and banks engaged in high-frequency trading, market making, liquidity provision, algorithmic trading, and smart order routing. Celoxica offers a range of market data feed handlers covering major U.S. and European equities, options, futures, and foreign exchange markets. The company facilitates seamless connectivity for brokers and clients by managing inbound FIX, credit checks, and outbound native protocols to execution venues. With additional offices in Chicago and New York, Celoxica remains focused on meeting the growing demands for speed and efficiency in electronic trading.
Haemostatix Ltd. is a biotechnology company based in Nottingham, United Kingdom, founded in 2003 as a spin-out from the University of Leicester. The company specializes in a peptide-based platform technology designed to develop innovative products for managing surgical bleeding, with potential applications in tissue repair and regenerative medicine. Its flagship product, PeproStat, is a topical coagulant that can be applied directly to wounds during surgery to effectively control bleeding. The technology is based on a specific peptide sequence that binds to fibrinogen, a crucial protein in clot formation, and can be adapted to various solid supports or soluble carriers. This platform underpins a promising pipeline of first-in-class products aimed at treating different forms of bleeding, including those associated with surgery, trauma, and leukaemia. As of 2016, Haemostatix operates as a subsidiary of Ergomed plc.
Kobalt is an independent music services company that provides technology-driven solutions designed to enhance transparency and efficiency for rights owners in the music industry. The company operates through its Music Publishing, Label Services, and Neighbouring Rights divisions, offering a modern alternative to traditional business models. Kobalt empowers artists, songwriters, and publishers by providing real-time reporting through its Kobalt Portal, along with global licensing management, royalty collection, and digital marketing services. With a workforce of over 275 employees and a client roster that includes prominent artists and songwriters, Kobalt represents more than 8,000 creators and 600,000 songs, significantly impacting the music charts. The company aims to ensure fair and accurate payment for its clients while navigating the complexities of the digital music landscape.
blinkbox music is an ad-supported music streaming service and integrated MP3 store that offers users an accessible way to enjoy music. Launched in 2007 and based in Oxford, it allows listeners to choose from thousands of themed stations, such as Top 40 Songs and Ultimate 80s Pop, or to create their own stations based on specific songs, artists, or genres. The service is available for free on the web and through mobile and tablet apps for both Android and iOS. Users can also save their favorite stations for offline listening, enhancing the convenience of the platform.
Vivacta Limited is a medical diagnostics company based in Sittingbourne, UK, specializing in point-of-care testing solutions. The company has created an innovative piezofilm technology platform that enhances the development of near-patient diagnostic products, achieving sensitivity and dynamic range comparable to laboratory tests. Vivacta has successfully developed a diagnostic test for thyroid stimulating hormone (TSH) and is currently focused on creating a multiple analyte cardiovascular diagnostic test. This test aims to facilitate rapid diagnosis in emergency and acute care settings, addressing the urgent need for timely detection of potential heart attacks and related medical conditions.
Skinkers is the UK based software developer that provides communication management software to help organisations overcome the current limitations of existing digital channels. We tick all the boxes! [Microsoft](http://www.crunchbase.com/organization/microsoft) and Skinkers signed a technology for equity deal in 2006, a first for Microsoft in Europe. Skinkers owns the intellectual property rights for the peer-to-peer technology developed by Microsoft Research. Microsoft has a minority equity stake in Skinkers. Skinkers and Microsoft won the UK Partnering for Innovation Award [this year](http://www.livestation.com/news/25-skinkers_and_microsoft_win_partnering_for_innovation_award). Livestation was released for beta testing in July to moderate [reviews](http://www.techcrunch.com/2007/07/06/first-look-at-livestation-not-much-to-report) and is expected to be released to the general public in the fall. While it is often compared to [Joost](http://www.crunchbase.com/organization/joost), Livestation is different in that it streams live video, as opposed to offering video On-Demand. Livestation official channels include Al Jazeera, BBC World News, Bloomberg Television, EuroNews (English, French, Italian and now Spanish), France 24, i>Tele, Russia Today and BBC World Service. A feature allowing viewers to add their own channels has just been launched and has over 400 channels already. To watch Livestation, users must download a free video player, which is available for beta [testing](http://www.livestation.com/user/signup). With added [funding](http://www.techcrunch.com/2007/10/29/skinkers-raises-16-million-series-b/), Skinkers is looking to compete in an increasingly [cluttered](http://www.techcrunch.com/2007/07/13/live-p2p-television-streaming-now/) P2P IPTV space with competitors like [Zattoo](http://www.crunchbase.com/organization/Zattoo), [Babelgum](http://www.crunchbase.com/organization/babelgum), [Next.TV](http://www.techcrunch.com/2007/09/05/more-competition-for-iptv-hp-launching-nexttv/), as well as a number of Chinese based companies ([Sopcast](http://www.techcrunch.com/2007/07/13/live-p2p-television-streaming-now/), [PPLive](http://www.techcrunch.com/2007/07/13/live-p2p-television-streaming-now/), [PPMate](http://www.techcrunch.com/2007/07/13/live-p2p-television-streaming-now/)).
EDEM develops and markets high performance discrete element method (DEM) simulation software, a CAE tool designed for simulation-based engineering of equipment that handle or process bulk particles. Bulk particles, also known as bulk materials or bulk solids, such as powders, granules, tablets and aggregates, are handled and processed in every major manufacturing and process industry, including, pharmaceutical, food processing, consumer packaged goods, mining, minerals processing, metals manufacturing, and construction and agricultural machinery. The Company’s ground-breaking EDEM Simulation Software provides advanced engineering and operational benefits to all industries handling and processing bulk materials, enabling them to reduce design prototyping time and costs, optimize equipment performance, increase productivity and operational efficiencies, and enhance product innovation. DEM Solutions provides EDEM® simulation software platform, EDEM BulkSim® software, and engineering support services to blue-chip companies around the world in mining & energy, equipment manufacturing and process industries. Founded in 2003, the Company is headquartered in Edinburgh (UK) with offices in Denver (USA), Yokohama (Japan) and Shenzhen (China) supporting direct sales in Europe, Americas, Japan, China, and Australia, and channel sales in the rest of the world. DEM Solutions also works with a network of industry-expert engineering service partners worldwide supporting customers in deployment of EDEM simulation technology to address engineering challenges involving bulk particles.
Skinkers is the UK based software developer that provides communication management software to help organisations overcome the current limitations of existing digital channels. We tick all the boxes! [Microsoft](http://www.crunchbase.com/organization/microsoft) and Skinkers signed a technology for equity deal in 2006, a first for Microsoft in Europe. Skinkers owns the intellectual property rights for the peer-to-peer technology developed by Microsoft Research. Microsoft has a minority equity stake in Skinkers. Skinkers and Microsoft won the UK Partnering for Innovation Award [this year](http://www.livestation.com/news/25-skinkers_and_microsoft_win_partnering_for_innovation_award). Livestation was released for beta testing in July to moderate [reviews](http://www.techcrunch.com/2007/07/06/first-look-at-livestation-not-much-to-report) and is expected to be released to the general public in the fall. While it is often compared to [Joost](http://www.crunchbase.com/organization/joost), Livestation is different in that it streams live video, as opposed to offering video On-Demand. Livestation official channels include Al Jazeera, BBC World News, Bloomberg Television, EuroNews (English, French, Italian and now Spanish), France 24, i>Tele, Russia Today and BBC World Service. A feature allowing viewers to add their own channels has just been launched and has over 400 channels already. To watch Livestation, users must download a free video player, which is available for beta [testing](http://www.livestation.com/user/signup). With added [funding](http://www.techcrunch.com/2007/10/29/skinkers-raises-16-million-series-b/), Skinkers is looking to compete in an increasingly [cluttered](http://www.techcrunch.com/2007/07/13/live-p2p-television-streaming-now/) P2P IPTV space with competitors like [Zattoo](http://www.crunchbase.com/organization/Zattoo), [Babelgum](http://www.crunchbase.com/organization/babelgum), [Next.TV](http://www.techcrunch.com/2007/09/05/more-competition-for-iptv-hp-launching-nexttv/), as well as a number of Chinese based companies ([Sopcast](http://www.techcrunch.com/2007/07/13/live-p2p-television-streaming-now/), [PPLive](http://www.techcrunch.com/2007/07/13/live-p2p-television-streaming-now/), [PPMate](http://www.techcrunch.com/2007/07/13/live-p2p-television-streaming-now/)).
StrategyEye operates a B2B intelligence platform that combines proprietary content with relevant global news and blog sources, organizing information by a structured taxonomy that includes companies, categories, and trigger events. The company offers two main solutions: content marketing and content monetization. Its content marketing services assist brands in becoming publishers by identifying breaking stories and enabling them to create and distribute their own content through various channels, enhancing thought leadership and supporting SEO efforts. In terms of content monetization, StrategyEye aids publishers and event organizers in developing premium B2B intelligence products, facilitating additional revenue through subscriptions and online advertising. The company provides a comprehensive service that includes editorial workflow, structured taxonomies, and output templates. StrategyEye's clientele includes notable organizations such as Haymarket, IPC, and TimeWarner, and it also produces its own intelligence products focused on the Digital Media and Cleantech sectors, which are offered to a global audience of executives and advisors on a subscription basis.
Mind Candy Ltd. is a multi-brand entertainment company based in London, United Kingdom, that specializes in developing online games for children and families, primarily for mobile and tablet platforms. Founded in 2003, the company is best known for its flagship product, Moshi Monsters, an engaging online game designed for kids. In addition to this, Mind Candy offers Moshi Monsters Village, a gaming application, and Moshi Monsters Magazine, which features puzzles, stories, and creative activities. The company has expanded its offerings to include Moshi Monsters Music, a music application, and the Moshling app, which introduces users to whimsical characters. Recently, Mind Candy has also launched a sleep and mindfulness app for kids, featuring melodic stories and guided meditation sessions aimed at promoting relaxation and mindfulness among young users.
Skinkers is the UK based software developer that provides communication management software to help organisations overcome the current limitations of existing digital channels. We tick all the boxes! [Microsoft](http://www.crunchbase.com/organization/microsoft) and Skinkers signed a technology for equity deal in 2006, a first for Microsoft in Europe. Skinkers owns the intellectual property rights for the peer-to-peer technology developed by Microsoft Research. Microsoft has a minority equity stake in Skinkers. Skinkers and Microsoft won the UK Partnering for Innovation Award [this year](http://www.livestation.com/news/25-skinkers_and_microsoft_win_partnering_for_innovation_award). Livestation was released for beta testing in July to moderate [reviews](http://www.techcrunch.com/2007/07/06/first-look-at-livestation-not-much-to-report) and is expected to be released to the general public in the fall. While it is often compared to [Joost](http://www.crunchbase.com/organization/joost), Livestation is different in that it streams live video, as opposed to offering video On-Demand. Livestation official channels include Al Jazeera, BBC World News, Bloomberg Television, EuroNews (English, French, Italian and now Spanish), France 24, i>Tele, Russia Today and BBC World Service. A feature allowing viewers to add their own channels has just been launched and has over 400 channels already. To watch Livestation, users must download a free video player, which is available for beta [testing](http://www.livestation.com/user/signup). With added [funding](http://www.techcrunch.com/2007/10/29/skinkers-raises-16-million-series-b/), Skinkers is looking to compete in an increasingly [cluttered](http://www.techcrunch.com/2007/07/13/live-p2p-television-streaming-now/) P2P IPTV space with competitors like [Zattoo](http://www.crunchbase.com/organization/Zattoo), [Babelgum](http://www.crunchbase.com/organization/babelgum), [Next.TV](http://www.techcrunch.com/2007/09/05/more-competition-for-iptv-hp-launching-nexttv/), as well as a number of Chinese based companies ([Sopcast](http://www.techcrunch.com/2007/07/13/live-p2p-television-streaming-now/), [PPLive](http://www.techcrunch.com/2007/07/13/live-p2p-television-streaming-now/), [PPMate](http://www.techcrunch.com/2007/07/13/live-p2p-television-streaming-now/)).
Haemostatix Ltd. is a biotechnology company based in Nottingham, United Kingdom, founded in 2003 as a spin-out from the University of Leicester. The company specializes in a peptide-based platform technology designed to develop innovative products for managing surgical bleeding, with potential applications in tissue repair and regenerative medicine. Its flagship product, PeproStat, is a topical coagulant that can be applied directly to wounds during surgery to effectively control bleeding. The technology is based on a specific peptide sequence that binds to fibrinogen, a crucial protein in clot formation, and can be adapted to various solid supports or soluble carriers. This platform underpins a promising pipeline of first-in-class products aimed at treating different forms of bleeding, including those associated with surgery, trauma, and leukaemia. As of 2016, Haemostatix operates as a subsidiary of Ergomed plc.
Aspex Semiconductor is a fabless semiconductor company that develops, manufactures, and distributes system-on-chip high-definition video compression and transcoding solutions for consumer electronic applications. It is specialized in the development of software programmable media processors and offers HD video transcoding chips. Aspex Semiconductor’s products are used in intelligent home gateways, PVR functionalities, Blu-ray or HD DVD recorders, networked digital televisions, television pause buttons, PCs and laptops, HD webcams, external adapters, and wireless HDMI applications. The company serves professional imaging and wireless infrastructure markets, including broadcast and digital cinema, medical imaging, machine vision, printing and document processing, and video compression markets. Aspex Semiconductor is based in Bradford, Somerset and, it sells its products through distributors in North America and the United Kingdom.
Xention Limited, a biopharmaceutical company, specializes in the discovery and development of ion channel-modulating drugs. It offers drugs for the treatment of atrial fibrillation, overactive bladder, pain, and autoimmune diseases. Xention Limited was formerly known as Xention Discovery Ltd. and later changed its name to Xention Limited in October 2006. The company was founded in 2002 and is based in Cambridge, the United Kingdom.
Touch Clarity is a content targeting software company that improves customer acquisition and revenue for large consumer websites. Touch Clarity builds profile data on website visitors and use that data to target content and increase revenue and profit measurably. The profile building is automatic, continuous and performed in real time so that as events and behaviour change the systems quickly learns and adapts the served propositions accordingly.
Aspex Semiconductor is a fabless semiconductor company that develops, manufactures, and distributes system-on-chip high-definition video compression and transcoding solutions for consumer electronic applications. It is specialized in the development of software programmable media processors and offers HD video transcoding chips. Aspex Semiconductor’s products are used in intelligent home gateways, PVR functionalities, Blu-ray or HD DVD recorders, networked digital televisions, television pause buttons, PCs and laptops, HD webcams, external adapters, and wireless HDMI applications. The company serves professional imaging and wireless infrastructure markets, including broadcast and digital cinema, medical imaging, machine vision, printing and document processing, and video compression markets. Aspex Semiconductor is based in Bradford, Somerset and, it sells its products through distributors in North America and the United Kingdom.
Event Zero Pty Ltd, founded in 2005 and headquartered in Eight Mile Plains, Australia, specializes in online content management and software solutions aimed at enhancing IT service operations. The company offers a platform that encompasses data management, business consulting, and interactive article publishing, along with conferencing services. As an independent software vendor, Event Zero focuses on providing products that deliver insights and intelligence, particularly for Microsoft Lync unified communications and green IT initiatives. In 2016, Event Zero became a subsidiary of Microsoft Corporation, further enhancing its capabilities within the technology sector.
Nomad Payments is a leading provider of prepaid and debit card processing and licensed software.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.